These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9017611)
1. Vancomycin resistant enterococci--a threat to the nephrologist on the horizon? Glycopeptide-resistant enterococci and ICDC-recommendations for a limited use of glycopeptides. Lameire N; Vogelaers D; Verschraegen G; Veys N Nephrol Dial Transplant; 1996 Dec; 11(12):2402-6. PubMed ID: 9017611 [No Abstract] [Full Text] [Related]
3. Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant gram-positive organisms. Fraise AP; Andrews J; Wise R J Antimicrob Chemother; 1997 Sep; 40(3):423-5. PubMed ID: 9338497 [TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. McDonald LC; Kuehnert MJ; Tenover FC; Jarvis WR Emerg Infect Dis; 1997; 3(3):311-7. PubMed ID: 9284375 [TBL] [Abstract][Full Text] [Related]
11. Validation of VITEK 2 version 4.01 software for detection, identification, and classification of glycopeptide-resistant enterococci. Abele-Horn M; Hommers L; Trabold R; Frosch M J Clin Microbiol; 2006 Jan; 44(1):71-6. PubMed ID: 16390951 [TBL] [Abstract][Full Text] [Related]
12. Vancomycin prescribing in the era of vancomycin-resistant enterococci. Polk R Pharmacotherapy; 1995; 15(5):682-3. PubMed ID: 8570444 [No Abstract] [Full Text] [Related]
14. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. Van der Auwera P; Pensart N; Korten V; Murray BE; Leclercq R J Infect Dis; 1996 May; 173(5):1129-36. PubMed ID: 8627064 [TBL] [Abstract][Full Text] [Related]
15. Occurrence of vancomycin-resistant enterococci in relation to the administration of glycopeptide antibiotics. Kolár M; Vágnerová I; Látal T; Kohnová I Acta Univ Palacki Olomuc Fac Med; 1999; 142():69-71. PubMed ID: 10743728 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin. Harland S; Tebbs SE; Elliott TS J Antimicrob Chemother; 1998 Feb; 41(2):273-6. PubMed ID: 9533471 [TBL] [Abstract][Full Text] [Related]
17. Glycopeptide resistance in enterococci. Méndez-Alvarez S; Pérez-Hernández X; Claverie-Martín F Int Microbiol; 2000 Jun; 3(2):71-80. PubMed ID: 11001535 [TBL] [Abstract][Full Text] [Related]
18. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci. van Den Braak N; Goessens W; van Belkum A; Verbrugh HA; Endtz HP J Clin Microbiol; 2001 Jan; 39(1):351-3. PubMed ID: 11136798 [TBL] [Abstract][Full Text] [Related]